XML 25 R7.htm IDEA: XBRL DOCUMENT v3.22.2
Condensed Statements of Redeemable Convertible Preferred Stock and Stockholders' Equity - USD ($)
Total
Lonza Ltd.
Common Stock
Common Stock
Lonza Ltd.
Additional Paid-in Capital
Additional Paid-in Capital
Lonza Ltd.
Accumulated Deficit
Accumulated Other Comprehensive Loss
Follow on public offering
Follow on public offering
Common Stock
Follow on public offering
Additional Paid-in Capital
At the market offering
At the market offering
Common Stock
At the market offering
Additional Paid-in Capital
Beginning balance at Dec. 31, 2020 $ 345,843,000   $ 54,000   $ 544,353,000   $ (198,564,000)              
Beginning balance, shares at Dec. 31, 2020     51,071,593                      
Exercise of stock options 487,000   $ 267,208,000   487,000                  
Vesting of early exercised stock options 9,000       9,000                  
Stock-based compensation expense 1,865,000       1,865,000                  
Unrealized gains (losses) on investments (47,000)             $ (47,000)            
Net Loss (21,220,000)           (21,220,000)              
Ending balance at Mar. 31, 2021 326,937,000   $ 54,000   546,714,000   (219,784,000) (47,000)            
Ending balance, shares at Mar. 31, 2021     51,338,801                      
Beginning balance at Dec. 31, 2020 345,843,000   $ 54,000   544,353,000   (198,564,000)              
Beginning balance, shares at Dec. 31, 2020     51,071,593                      
Net Loss (44,899,000)                          
Ending balance at Jun. 30, 2021 317,025,000   $ 55,000   560,441,000   (243,463,000) (8,000)            
Ending balance, shares at Jun. 30, 2021     51,963,770                      
Beginning balance at Mar. 31, 2021 326,937,000   $ 54,000   546,714,000   (219,784,000) (47,000)            
Beginning balance, shares at Mar. 31, 2021     51,338,801                      
Exercise of stock options 466,000   $ 190,003   466,000                  
Vesting of early exercised stock options 2,000       2,000                  
Issuance of common stock under employee stock purchase plan 490,000       490,000                  
Stock Issued During Period, Shares, Employee Stock Purchase Plans (in shares)     35,286                      
Issuance of common stock, value   $ 10,001,000   $ 1,000   $ 10,000,000                
Issuance of common stock, shares   399,680                        
Stock-based compensation expense 2,769,000       2,769,000                  
Unrealized gains (losses) on investments 39,000             39,000            
Net Loss (23,679,000)           (23,679,000)              
Ending balance at Jun. 30, 2021 317,025,000   $ 55,000   560,441,000   (243,463,000) (8,000)            
Ending balance, shares at Jun. 30, 2021     51,963,770                      
Beginning balance at Dec. 31, 2021 284,018,000   $ 56,000   582,844,000   (298,641,000) (241,000)            
Beginning balance, shares at Dec. 31, 2021     53,031,978                      
Exercise of stock options 282,000       282,000                  
Exercise of stock options (in shares)     91,044                      
Vesting of early exercised stock options 2,000       2,000                  
Issuance of common stock, value                 $ 107,622,000 $ 3,000 $ 107,619,000 $ 3,098,000   $ 3,098,000
Issuance of common stock, shares                   3,250,000     126,522  
Stock-based compensation expense 4,099,000       4,099,000                  
Unrealized gains (losses) on investments (592,000)             (592,000)            
Net Loss (38,986,000)           (38,986,000)              
Ending balance at Mar. 31, 2022 359,543,000   $ 59,000   697,944,000   (337,627,000) (833,000)            
Ending balance, shares at Mar. 31, 2022     56,499,544                      
Beginning balance at Dec. 31, 2021 284,018,000   $ 56,000   582,844,000   (298,641,000) (241,000)            
Beginning balance, shares at Dec. 31, 2021     53,031,978                      
Net Loss (87,518,000)                          
Ending balance at Jun. 30, 2022 366,500,000   $ 62,000   753,501,000   (386,159,000) (904,000)            
Ending balance, shares at Jun. 30, 2022     58,624,294                      
Beginning balance at Mar. 31, 2022 359,543,000   $ 59,000   697,944,000   (337,627,000) (833,000)            
Beginning balance, shares at Mar. 31, 2022     56,499,544                      
Exercise of stock options 324,000   $ 1,000   323,000                  
Exercise of stock options (in shares)     77,065                      
Vesting of early exercised stock options 2,000       2,000                  
Issuance of common stock under employee stock purchase plan 550,000       550,000                  
Stock Issued During Period, Shares, Employee Stock Purchase Plans (in shares)     36,879                      
Issuance of common stock, value                 $ 2,000   $ 2,000 $ 48,788,000 $ 2,000 $ 48,786,000
Issuance of common stock, shares                         2,010,806  
Stock-based compensation expense 5,894,000       5,894,000                  
Unrealized gains (losses) on investments (71,000)             (71,000)            
Net Loss (48,532,000)           (48,532,000)              
Ending balance at Jun. 30, 2022 $ 366,500,000   $ 62,000   $ 753,501,000   $ (386,159,000) $ (904,000)            
Ending balance, shares at Jun. 30, 2022     58,624,294